191 related articles for article (PubMed ID: 1332441)
1. Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH).
Samama MM
Adv Exp Med Biol; 1992; 313():275-81. PubMed ID: 1332441
[No Abstract] [Full Text] [Related]
2. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis.
Prandoni P; Lensing AW; Büller HR; Carta M; Cogo A; Vigo M; Casara D; Ruol A; ten Cate JW
Lancet; 1992 Feb; 339(8791):441-5. PubMed ID: 1346817
[TBL] [Abstract][Full Text] [Related]
3. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
[TBL] [Abstract][Full Text] [Related]
4. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
Agnelli G
Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
[No Abstract] [Full Text] [Related]
5. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
6. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
[No Abstract] [Full Text] [Related]
7. Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.
Bergqvist D
Acta Chir Scand Suppl; 1988; 543():87-9. PubMed ID: 2847463
[No Abstract] [Full Text] [Related]
8. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomised clinical trials.
Palmer AJ; Schramm W; Kirchhof B; Bergemann R
Haemostasis; 1997; 27(2):65-74. PubMed ID: 9212354
[TBL] [Abstract][Full Text] [Related]
10. Prevention and therapy of postoperative thrombosis and embolism.
Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G
Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020
[No Abstract] [Full Text] [Related]
11. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery.
Steiner RA; Keller K; Lüscher T; Schreiner WE
Arch Gynecol Obstet; 1989; 244(3):141-50. PubMed ID: 2544152
[TBL] [Abstract][Full Text] [Related]
13. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
[TBL] [Abstract][Full Text] [Related]
14. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
Valiukiene L; Naudziūnas A; Unikauskas A
Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903
[TBL] [Abstract][Full Text] [Related]
15. A comparison of low molecular weight heparin and low dose unfractionated heparin prophylaxis in subacute myelopathy.
Spivack SB; Aisen ML
J Spinal Cord Med; 1997 Oct; 20(4):402-5. PubMed ID: 9360220
[TBL] [Abstract][Full Text] [Related]
16. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture.
Monreal M; Lafoz E; Navarro A; Granero X; Caja V; Caceres E; Salvador R; Ruiz J
J Trauma; 1989 Jun; 29(6):873-5. PubMed ID: 2544742
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis.
Hirsh J
Haemostasis; 1996 Oct; 26 Suppl 4():189-98. PubMed ID: 8979124
[TBL] [Abstract][Full Text] [Related]
18. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
[TBL] [Abstract][Full Text] [Related]
19. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
[TBL] [Abstract][Full Text] [Related]
20. Management of venous thromboembolism: optimization by clinical trials.
Turpie AG
Haemostasis; 1996 Oct; 26 Suppl 4():220-6. PubMed ID: 8979127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
